Pharmaron Beijing Co., Ltd. (HKG:3759)
Hong Kong
· Delayed Price · Currency is HKD 16.50
-0.40 (-2.37%)
Apr 2, 2025, 1:45 PM HKT
Pharmaron Beijing Market Cap
Pharmaron Beijing has a market cap or net worth of 47.33 billion as of April 1, 2025. Its market cap has increased by 16.28% in one year.
Market Cap
47.33B
Enterprise Value
51.09B
Revenue
13.06B
Ranking
n/a
PE Ratio
24.80
Stock Price
16.50
Market Cap Chart
Since January 28, 2019, Pharmaron Beijing's market cap has increased from 8.42B to 47.33B, an increase of 462.00%. That is a compound annual growth rate of 32.25%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 223.66B |
| Hansoh Pharmaceutical Group Company | 140.05B |
| WuXi Biologics | 109.81B |
| JD Health International | 106.07B |
| Alibaba Health Information Technology | 75.74B |
| Innovent Biologics | 75.68B |
| Akeso | 68.39B |
| Sino Biopharmaceutical | 67.05B |